Analyst firms · Susquehanna · CHRW
Susquehanna CHRW price target and rating history
C.H. Robinson Worldwide Inc. (CHRW) · Industrials
Susquehanna rates C.H. Robinson Worldwide Inc. (CHRW) Positive with a $130 price target, as of its latest action on Jan 3, 2025. It has published 3 rating actions on CHRW since August 2023, including 2 upgrades and 1 downgrade. Across 6 firms with a CHRW price target in the last 12 months, the median target is $192.50.
- Current rating
- Positive
- Price target
- $130
- Median target, all firms
- $192.50
- Actions on CHRW
- 3
Susquehanna price target on CHRW
Every Susquehanna rating on CHRW
- Jan 3, 2025
- Jan 10, 2024
- Aug 31, 2023
How other firms rate CHRW
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Deutsche Bank | Hold | $153 | Oct 12, 2026 |
| Citigroup | Buy | $185 | Sep 8, 2026 |
| TD Cowen | Hold | $152 | Jul 30, 2026 |
| Citizens JMP | Mkt Perform | $235 | Jul 15, 2026 |
| Jefferies | Buy | $200 | May 20, 2026 |
| Barclays | Overweight | $200 | Dec 16, 2025 |
Questions about Susquehanna and CHRW
- What is Susquehanna's price target for CHRW?
- Susquehanna's latest stated price target for C.H. Robinson Worldwide Inc. (CHRW) is $130, from its action on Jan 3, 2025.
- What is Susquehanna's rating on CHRW?
- Susquehanna rates CHRW Positive, a bullish rating, as of Jan 3, 2025.
- When did Susquehanna last change its view on CHRW?
- On Jan 3, 2025, Susquehanna upgrades to Positive from Neutral, price target $115 to $130.
- How does Susquehanna's CHRW target compare with other analysts?
- Across 6 firms with a CHRW price target in the last 12 months, the median target is $192.50.
More CHRW rating histories
- Citigroup9
- TD Cowen12
- Barclays5
- Wolfe Research5
- Stifel3
- Raymond James3
- Wells Fargo3
- UBS3
- J.P. Morgan6
- BofA Securities5
- Vertical Research4
All Susquehanna ratingsCHRW news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.